How is lysosomal acid lipase deficiency diagnosed?
LAL-D is diagnosed by a blood test that measures the activity of the LAL enzyme. Other supportive tests that your healthcare provider may order include genetic testing and a liver biopsy.
What diseases are associated with lipase?
Three rare lipid storage diseases are caused by the deficiency of the enzyme lysosomal acid lipase:
- Lysosomal acid lipase deficiency (LAL-D)
- Wolman disease (early onset lysosomal acid lipase deficiency)
- Cholesteryl ester storage disease (CESD)
What is Wolman disease?
Wolman disease is a type of lysosomal acid lipase (LAL) deficiency; a rare genetic disorder characterized by complete absence of an enzyme known as lysosomal acid lipase (LIPA or LAL). This enzyme is required to breakdown (metabolize) certain fats (lipids) in the body.
How common is lysosomal acid lipase deficiency?
Lysosomal acid lipase deficiency is estimated to occur in 1 in 40,000 to 300,000 individuals, varying by population. The later-onset form is more common than the early-onset form.
What is a lipid deficiency?
Acid lipase disease or deficiency occurs when the enzyme needed to break down certain fats that are normally digested by the body is lacking or missing, resulting in the toxic buildup of these fats in the body’s cells and tissues. These fatty substances, called lipids, include fatty acids, oils, and cholesterol.
What causes a lack of lipase?
Familial lipoprotein lipase deficiency is caused by a defective gene that is passed down through families. People with this condition lack an enzyme called lipoprotein lipase. Without this enzyme, the body cannot break down fat from digested food. Fat particles called chylomicrons build up in the blood.
What is the pathophysiology of lysosomal acid lipase deficiency?
Deficiency of lysosomal acid lipase causes 2 distinct phenotypes in humans: Wolman disease and cholesteryl ester storage disease (CESD). Wolman disease is an early-onset fulminant disorder of infancy with massive infiltration of the liver, spleen, and other organs by macrophages filled with cholesteryl esters and triglycerides.
What is the role of lipase a in Wolman disease?
Lysosomal acid lipase A, the enzyme deficient in both Wolman disease and cholesterol ester storage disease, is one of 3 acid lipase isozymes. See lipase B (LIPB; 247980) and C (LIPC; 151670 ).
Are there any FDA approved Orphan Products for lysosomal acid lipase deficiency?
The medication (s) listed below have been approved by the Food and Drug Administration (FDA) as orphan products for treatment of this condition. Learn more orphan products. FDA-approved indication: Indicated for the treatment of patients with a diagnosis of lysosomal acid Lipase (LAL) deficiency.
What is severe infantile lysosomal lipid storage disease (Sele)?
Severe infantile form of inherited lysosomal lipid storage disease due to deficiency of acid lipase; results in accumulation of neutral lipids, particularly cholesterol esters, within cells. The severe infantile form of inherited lysosomal lipid storage diseases due to deficiency of acid lipase (sterol esterase).